|

SNK01 Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • NKGen Biotech, Inc.2

Indications

  • Alzheimer's Disease2
  • Moderate Alzheimer Disease1
  • Alzheimer Disease1

Glendale, California2 trials

Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease

Behavioral Research Specialists, LLC

Phase 1/2
Open-Label Extension Protocol to SNK01-AD01 Study

Behavioral Research Specialists, LLC

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.